NCT01883661 Safety and Efficacy of BMMNC in Multiple Sclerosis (MS) Status UNKNOWN Phase PHASE1/PHASE2
NCT01881191 Th Effects of Aubagio on Brain Pathology in Multiple Sclerosis Studied Over 12 Months Status COMPLETED Phase N/A
NCT01879202 Methylphenidate as Treatment Option of Fatigue in Multiple Sclerosis Status UNKNOWN Phase PHASE2
NCT01874340 Efficacy and Safety of AIN457 (Secukinumab) in Patients With Relapsing Multiple Sclerosis Status TERMINATED Phase PHASE2
NCT01871818 A Trial to Compare the Effectiveness of Two Rehabilitation Programs for Multiple Sclerosis Patients Status COMPLETED Phase NA
NCT01871337 Exercises for Urinary Incontinence(UI) of Women With Multiple Sclerosis (MS) Status COMPLETED Phase NA
NCT01868048 Phase 3, 28-week, Randomized, Double-blind, Placebo-controlled Safety and Efficacy Study of Nabiximols as an add-on Therapy in Subjects With Spasticity Due to Multiple Sclerosis. Status WITHDRAWN Phase PHASE3
NCT01866878 Rehabilitation Protocol for Disorders on Hand Sensitivity in Multiple Sclerosis Patients. Status TERMINATED Phase NA
NCT01865357 Prospective Longitudinal 1-year Study of the Correlation Between Cognitive Functioning in Patients With Clinically Isolated Syndrome Suggestive of Multiple Sclerosis and Disconnection in the Brain Assessed by MRI Status COMPLETED Phase NA
NCT01864941 Interventional Clinical Trial for CCSVI in Multiple Sclerosis Patients Status COMPLETED Phase PHASE1/PHASE2
NCT01864148 Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Participants With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex Status COMPLETED Phase PHASE2
NCT01863888 Effect of Teriflunomide on Immune Cell Subsets in the Blood of Patients With Multiple Sclerosis Status COMPLETED Phase PHASE3
NCT01854359 Idebenone for Primary Progressive Multiple Sclerosis Status COMPLETED Phase PHASE1/PHASE2
NCT01847287 A Longitudinal Study of Brain Atrophy in MS Patients Over 5 Years Status COMPLETED Phase N/A
NCT01845896 Influence of High Intensity Exercise on Insulin Resistance, Muscle Contractile Properties, Aerobic Capacity and Body Composition in Multiple Sclerosis Status COMPLETED Phase NA
NCT01844232 One Year, Open Label, Dose Escalation Long-term Safety Study in Multiple Sclerosis (MS) Subjects With Spasticity Status COMPLETED Phase PHASE3